Skip to main content
SpringerLink
Log in

Oat β-glucan cost effective for CHD prevention

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 US dollars

  2. HMG-CoA reductase inhibitors

Reference

  • Earnshaw SR, et al. Cost-Effectiveness of Maintaining Daily Intake of Oat beta-Glucan for Coronary Heart Disease Primary Prevention. Clinical Therapeutics : 24 Mar 2017. Available from: URL: http://doi.org/10.1016/j.clinthera.2017.02.012

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oat β-glucan cost effective for CHD prevention. PharmacoEcon Outcomes News 776, 24 (2017). https://doi.org/10.1007/s40274-017-3926-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3926-7

Search

Navigation